Another study by Signorelli et al. evaluated plasma inflammatory markers, namely, interleukin (IL)-6 and tumor necrosis factor (TNF)-α, in patients with peripheral arterial disease compared with controls [80]. The gene discussed is IL6; the disease is peripheral arterial disease.